Asia Pacific 3d Printed Drugs Market Size & Outlook
Asia Pacific 3d printed drugs market, 2018-2030 (US$M)
Related Markets
Asia Pacific 3d printed drugs market highlights
- The Asia Pacific 3d printed drugs market generated a revenue of USD 20.4 million in 2023.
- The market is expected to grow at a CAGR of 16.6% from 2024 to 2030.
- In terms of segment, neurology was the largest revenue generating application in 2023.
- Orthopedic is the most lucrative application segment registering the fastest growth during the forecast period.
- Country-wise, India is expected to register the highest CAGR from 2024 to 2030.
Asia Pacific data book summary
| Market revenue in 2023 | USD 20.4 million |
| Market revenue in 2030 | USD 60.0 million |
| Growth rate | 16.6% (CAGR from 2023 to 2030) |
| Largest segment | Neurology |
| Fastest growing segment | Orthopedic |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Dental, Orthopedic, Neurology |
| Key market players worldwide | GlaxoSmithKline, Hewlett Packard Enterprise Co, Merck KGaA, AstraZeneca PLC, Aprecia Pharmaceuticals, Extend Biosciences, BioDuro, Affini-T Therapeutics, Osmotica Pharmaceutical, FabRx, Cycle Pharmaceuticals |
Other key industry trends
- In terms of revenue, Asia Pacific region accounted for 19.9% of the global 3d printed drugs market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 60.0 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
3D Printed Drugs Market Scope
3D Printed Drugs Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Asia Pacific 3d printed drugs market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to 3d printed drugs market will help companies and investors design strategic landscapes.
Neurology was the largest segment with a revenue share of 50.98% in 2023. Horizon Databook has segmented the Asia Pacific 3d printed drugs market based on dental, orthopedic, neurology covering the revenue growth of each sub-segment from 2018 to 2030.
Asia Pacific is anticipated to grow at the highest CAGR during the forecast period owing to economic development and the high unmet medical needs of large population in China & India. Increasing healthcare awareness among individuals and growing technological advancements in emerging economies are among the factors anticipated to contribute to market growth.
The growing geriatric population in Asian countries, such as India and China, with large untapped opportunities, is expected to drive market growth during the forecast period. For instance, according to WHO, the proportion of people aged over 60 in China is expected to reach 28% by 2040 due to increased life expectancy and lower fertility rates.
Reasons to subscribe to Asia Pacific 3d printed drugs market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Asia Pacific 3d printed drugs market databook
-
Our clientele includes a mix of 3d printed drugs market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific 3d printed drugs market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific 3d printed drugs market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Asia Pacific 3d printed drugs market size, by country, 2018-2030 (US$M)
Asia Pacific 3D Printed Drugs Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
